HBE1 and Hepatitis: Indeed, in an observational study, it was reported that when BG was given with the antiviral drug telbivudine for the treatment of hepatitis in the clinic, the liver function (ALT) normalization rate, HBV DNA and hepatitis B virus markers (HBeAg) negative conversion rate, and anti-HBe serum conversion rate in the treatment group (BG and telbivudine, n = 64) were significantly higher compared to the reference group (telbivudine alone, n = 62) (Fang et al., 2011).